Your Messages Inbox
Most Viewed Abstracts
1. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 2. Omega-3 fatty acids for bipolar disorder 3. Is folic acid good for everyone 4. ACS Releases Guidelines for HPV Vaccination 5. Vitamin D - A review Free full text
Your Article Summary
See Latest ArticlesPrimary prevention of cardiovascular mortality and events with statin treatments: A network meta-analysis involving more than 65,000 patients
JACC - Journal of the American College of Cardiology, 11/21/08
Mills EJ et al. – Statins have a clear role in primary prevention of cardiovascular disease (CVD) mortality and major events.
Methods- Study to evaluate effectiveness of 3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitors (statins) in primary prevention of cardiovascular events
- Comprehensive searches of 10 electronic databases from inception to May 2008
- Contact of study investigators for maintainence of a comprehensive bibliography of statin studies
- Review of randomized trials of ≥12-mo duration in predominantly primary prevention populations
- Independent data extraction in duplicate by 2 reviewers
- Random-effects meta-analysis and meta-regression, calculation of optimal information size, and mixed-treatment comparison analysis
- Of 20 randomized clinical trials, 19 trials pooled (63,899 pts) for all-cause mortality
- Pooled data showed relative risk (RR) of 0.93
- Cardiovascular deaths assessed in 18 trials (59,469 pts)
- Major cardiovascular events assessed in 17 trials (53,371 pts) with RR of 0.85; 17 trials (52,976 pts) assessed myocardial infarctions
- Incidence of cancer not elevated in 10 trials (45,469 pts) nor was rhabdomyolysis
- Analysis included a sufficient sample to reliably answer primary outcome of CVD mortality
Today in Atherosclerosis/Lipids...keeping you current
Receive free subspecialty "5-minute updates" via email
Biphasic effects of hormone treatment on risk of cardiovascular disease
Sexuality, Reproduction & Menopause, 10/20/09
Effects of prescription omega-3-acid ethyl esters on lipoprotein particle concentrations, apolipoproteins AI and CIII, and lipoprotein-associated phospholipase A2 mass in statin-treated subjects with hypertriglyceridemia
Journal of Clinical Lipidology, 10/14/09
Prevalence of Unresponsiveness to Aspirin and/or Clopidogrel in Patients With Stable Coronary Heart Disease
The American Journal of Cardiology, 10/21/09
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Novel Therapies for Pemphigus Vulgaris: An Overview
Drugs & Aging, 09/21/09
New Anticoagulants in Atrial Fibrillation
Seminars in Thrombosis and Hemostasis, 10/02/09
Antithrombotic medication for stroke prevention
Expert Review of Cardiovascular Therapy , 10/20/09
Today in General Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Acute Coronary Syndromes: Diagnosis and Management, Part I
Mayo Clinic Proceedings, 10/05/09
New Anticoagulants in Atrial Fibrillation
Seminars in Thrombosis and Hemostasis, 10/02/09
Escitalopram and Venlafaxine for the Prophylaxis of Migraine Headache Without Mood Disorders
Clinical Neuropharmacology, 10/02/09
Today in Primary Care...keeping you current
Receive free subspecialty "5-minute updates" via email
Sponsor
Article Search
Sponsor
Sponsor